TMS Co (TSE:4891) Debt-to-Asset : 0.00 (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is TMS Co Debt-to-Asset?

TMS Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was 円0.00 Mil. TMS Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was 円0.00 Mil. TMS Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Nov. 2023 was 円3,229.84 Mil. TMS Co's debt to asset for the quarter that ended in Nov. 2023 was 0.00.

TMS Co Debt-to-Asset Historical Data

The historical data trend for TMS Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co Debt-to-Asset Chart

TMS Co Annual Data

Trend

Feb21

Feb22

Feb23

Debt-to-Asset

TMS Co Quarterly Data
	Feb21	Feb22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Debt-to-Asset	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of TMS Co's Debt-to-Asset

For the Biotechnology subindustry, TMS Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMS Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TMS Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where TMS Co's Debt-to-Asset falls into.

TMS Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

TMS Co's Debt-to-Asset for the fiscal year that ended in Feb. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	3790.215
	=	0.00

TMS Co's Debt-to-Asset for the quarter that ended in Nov. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	3229.837
	=	0.00

TMS Co (TSE:4891) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

TMS Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of TMS Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

TMS Co (TSE:4891) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055

Website

https://www.tms-japan.co.jp

TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines